Patents Assigned to RARECELLS SAS
  • Publication number: 20200264166
    Abstract: A process for isolating or extracting rare cells from a biological sample comprising filtering a biological sample, which may be treated or diluted, through a filter that has a pore size, pore density or other physical properties that retain rare cells, but which permits other kinds of cells to pass through the filter. This process also comprises multiple analyses performed on rare cells after their extraction or isolation by filtration to diagnostically identify the presence of rare cells in a biological sample and to use their diagnostic identification and molecular characterization for diagnostic purposes such as for early diagnosis of diseases, namely for early diagnosis of cancer and to select, guide, monitor treatments and in particular to select targeted treatments and to monitor the response and/or resistance to them.
    Type: Application
    Filed: January 17, 2020
    Publication date: August 20, 2020
    Applicants: RARECELLS SAS, UNIVERSITE DE NICE SOPHIA ANTIPOLIS, CENTRE HOSPITALIER UNIVERSITAIRE DE NICE, UNIVERSITE PARIS DESCARTES, Assistance Publique-Hopitaux de Paris (AP-HP), Institut National de la Sante et de la Recherche Medicale (Inserm)
    Inventors: Patrizia PATERLINI-BRECHOT, Paul HOFMAN, Sophie Marie Genevieve LAGET, Thierry CAPIOD
  • Publication number: 20130316347
    Abstract: A process for isolating or extracting rare cells from a biological sample comprising filtering a biological sample, which may be treated or diluted, through a filter that has a pore size, pore density or other physical properties that retain rare cells, but which permits other kinds of cells to pass through the filter. This process also comprises multiple analyses performed on rare cells after their extraction or isolation by filtration to diagnostically identify the presence of rare cells in a biological sample and to use their diagnostic identification and molecular characterization for diagnostic purposes such as for early diagnosis of diseases, namely for early diagnosis of cancer and to select, guide, monitor treatments and in particular to select targeted treatments and to monitor the response and/or resistance to them.
    Type: Application
    Filed: May 23, 2013
    Publication date: November 28, 2013
    Applicant: RARECELLS SAS
    Inventors: Patrizia PATERLINI BRECHOT, Paul Hofman, Sophie Laget, Thierry Capiod